Narrowband UVB phototherapy for early-stage XXXX .

@entity4888 @entity1
BACKGROUND: Narrowband UVB (NB-UVB) phototherapy has been shown to be effective for the treatment of various dermatoses. OBJECTIVE: We evaluated the effect of NB-UVB in the treatment of early stage @entity4888 ( @entity4888 ). METHODS: The response of 24 @entity1 (12 stage IA, 12 stage IB) with patch stage @entity4888 to thrice weekly NB-UVB was assessed. Twelve @entity1 had skin phototypes I-III, and 12 had types IV-VI. Seven @entity1 had hypopigmented @entity4888 . Mean follow-up period was 29.0 weeks. RESULTS: Thirteen @entity1 (54.2%) had a complete response (CR), 7 (29.2%) had partial response (PR), and 4 (16.7%) had no response. Specimens from a repeat biopsy in 10 @entity1 with CR showed histologic clearing in 9 of them. Upon discontinuation of treatment, 4 @entity1 with CR relapsed, with a mean time to relapse of 12.5 weeks. CONCLUSION: NB-UVB is a viable, comparably safe, and easily administered alternative in the management of early stage @entity4888 .
